YungShin Global Holding Corporation (3705.TW)
TWD 65.0
(-1.07%)
TWD 65.0
(-1.07%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 241.99 Million TWD | 63.95% |
| 2022 | 147.6 Million TWD | -79.16% |
| 2021 | 708.31 Million TWD | -26.05% |
| 2020 | 957.88 Million TWD | 166.11% |
| 2019 | 359.95 Million TWD | -8.47% |
| 2018 | 393.28 Million TWD | 411.94% |
| 2017 | 76.82 Million TWD | -80.25% |
| 2016 | 388.98 Million TWD | -19.54% |
| 2015 | 483.44 Million TWD | 248.71% |
| 2014 | 138.63 Million TWD | -7.73% |
| 2013 | 150.26 Million TWD | 68.9% |
| 2012 | 88.96 Million TWD | 0.0% |
| 2011 | - TWD | -100.0% |
| 2010 | 67.24 Million TWD | -12.72% |
| 2009 | 77.04 Million TWD | -1.9% |
| 2008 | 78.53 Million TWD | 0.0% |
| 2006 | 3.2 Million TWD | -62.66% |
| 2005 | 8.57 Million TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 298.18 Million TWD | 23.22% |
| 2024 Q1 | 253.9 Million TWD | -0.0% |
| 2023 Q2 | 253.34 Million TWD | -0.68% |
| 2023 Q3 | 251.41 Million TWD | -0.76% |
| 2023 Q1 | 255.08 Million TWD | 72.82% |
| 2023 Q4 | 241.99 Million TWD | -3.75% |
| 2023 FY | 241.99 Million TWD | 63.95% |
| 2022 Q1 | 956.65 Million TWD | 35.06% |
| 2022 Q4 | 147.6 Million TWD | -58.71% |
| 2022 Q3 | 357.46 Million TWD | -62.47% |
| 2022 Q2 | 952.47 Million TWD | -0.44% |
| 2022 FY | 147.6 Million TWD | -79.16% |
| 2021 FY | 708.31 Million TWD | -26.05% |
| 2021 Q4 | 708.31 Million TWD | 0.11% |
| 2021 Q3 | 707.55 Million TWD | -0.82% |
| 2021 Q2 | 713.38 Million TWD | -25.71% |
| 2021 Q1 | 960.31 Million TWD | 0.25% |
| 2020 Q1 | 150.05 Million TWD | -58.31% |
| 2020 FY | 957.88 Million TWD | 166.11% |
| 2020 Q2 | 604.87 Million TWD | 303.11% |
| 2020 Q3 | 675.98 Million TWD | 11.75% |
| 2020 Q4 | 957.88 Million TWD | 41.7% |
| 2019 FY | 359.95 Million TWD | -8.47% |
| 2019 Q2 | 420.98 Million TWD | 1.87% |
| 2019 Q3 | 297.63 Million TWD | -29.3% |
| 2019 Q4 | 359.95 Million TWD | 20.94% |
| 2019 Q1 | 413.26 Million TWD | 5.08% |
| 2018 Q2 | 26.4 Million TWD | -2.09% |
| 2018 FY | 393.28 Million TWD | 411.94% |
| 2018 Q3 | 353.95 Million TWD | 1240.43% |
| 2018 Q4 | 393.28 Million TWD | 11.11% |
| 2018 Q1 | 26.96 Million TWD | -64.89% |
| 2017 Q3 | 329.98 Million TWD | -0.45% |
| 2017 Q2 | 331.48 Million TWD | -14.08% |
| 2017 Q1 | 385.8 Million TWD | -0.82% |
| 2017 FY | 76.82 Million TWD | -80.25% |
| 2017 Q4 | 76.82 Million TWD | -76.72% |
| 2016 FY | 388.98 Million TWD | -19.54% |
| 2016 Q2 | 343.07 Million TWD | -29.66% |
| 2016 Q4 | 388.98 Million TWD | 13.96% |
| 2016 Q1 | 487.73 Million TWD | 0.89% |
| 2016 Q3 | 341.34 Million TWD | -0.5% |
| 2015 Q3 | 493.03 Million TWD | 172.95% |
| 2015 FY | 483.44 Million TWD | 248.71% |
| 2015 Q4 | 483.44 Million TWD | -1.94% |
| 2015 Q2 | 180.63 Million TWD | -3.05% |
| 2015 Q1 | 186.31 Million TWD | 34.39% |
| 2014 Q3 | 141.69 Million TWD | -2.3% |
| 2014 Q2 | 145.02 Million TWD | -6.92% |
| 2014 Q1 | 155.81 Million TWD | 3.69% |
| 2014 FY | 138.63 Million TWD | -7.73% |
| 2014 Q4 | 138.63 Million TWD | -2.16% |
| 2013 Q1 | 92.2 Million TWD | 3.64% |
| 2013 Q2 | 92.38 Million TWD | 0.19% |
| 2013 Q4 | 150.26 Million TWD | -10.67% |
| 2013 Q3 | 168.2 Million TWD | 82.08% |
| 2013 FY | 150.26 Million TWD | 68.9% |
| 2012 Q2 | 92.89 Million TWD | 0.0% |
| 2012 Q3 | 90.42 Million TWD | -2.66% |
| 2012 Q4 | 88.96 Million TWD | -1.62% |
| 2012 FY | 88.96 Million TWD | 0.0% |
| 2012 Q1 | - TWD | 0.0% |
| 2011 Q3 | 67.81 Million TWD | 4.91% |
| 2011 FY | - TWD | -100.0% |
| 2011 Q1 | - TWD | -100.0% |
| 2011 Q2 | 64.64 Million TWD | 0.0% |
| 2011 Q4 | - TWD | -100.0% |
| 2010 FY | 67.24 Million TWD | -12.72% |
| 2010 Q4 | 67.24 Million TWD | 0.0% |
| 2009 FY | 77.04 Million TWD | -1.9% |
| 2008 FY | 78.53 Million TWD | 0.0% |
| 2006 FY | 3.2 Million TWD | -62.66% |
| 2005 FY | 8.57 Million TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Grape King Bio Ltd | 136.36 Million TWD | -77.468% |
| Standard Chem & Pharm CO., LTD. | 222.97 Million TWD | -8.532% |
| Maywufa Company Ltd. | 438.97 Million TWD | 44.873% |
| ScinoPharm Taiwan, Ltd. | 570.23 Million TWD | 57.562% |
| Lotus Pharmaceutical Co., Ltd. | 9.51 Billion TWD | 97.458% |
| LIWANLI Innovation Co., Ltd. | 361 Thousand TWD | -66934.903% |
| PhytoHealth Corporation | 17.46 Million TWD | -1286.002% |
| SCI Pharmtech, Inc. | 845.52 Million TWD | 71.379% |
| Formosa Laboratories, Inc. | 2.03 Billion TWD | 88.125% |
| PharmaEssentia Corporation | 954.99 Million TWD | 74.66% |
| Bora Pharmaceuticals Co., LTD. | 3.48 Billion TWD | 93.06% |